当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.Inclusion Criteria

Meet option 1 and 2 or option 1 and 3:

Aged 50 to 74
/
Primary lung cancer patients with pathological diagnosis and without clinical treatment or patients with pulmonary lesions highly suspicious for lung cancer and without prior treatment

1.2.Exclusion Criteria

Without diseases as listed following:

Diabetes
/
Other malignant tumors except lung cancer
/
Asthma
/
Severe liver dysfunction
/
End-stage renal disease
/
Acute inflammation

1.3.Informed Consent Form Signature

Inform Consent Form Signature

Yes

2.Baseline
2.1.General information
2.2.1.2.1.1、Case Number/ID Number

Case Number/ID Number

368375

2.2.1.2.1.2、Name

Name

ZYLA

2.2.1.2.1.3、Gender

Gender

Female

2.2.1.2.1.4、Age

Age

63

2.2.1.2.1.5、Height

Height

145 cm

2.2.1.2.1.6、Weight

Weight

69 kg

2.2.1.2.1.7、Education

Education

Illiterate

2.2.1.2.1.8、Own Phone Number

Own Phone Number

2.2.1.2.1.9、Relatives Phone Number

Relatives Phone Number

18180819195

2.2.1.2.1.10、Relatives Name

Relatives Name

2.2.Past History
2.2.2.2.2.1、Smoking History

Smoking History

No

2.2.2.2.2.2、Drinking History

Drinking History

No

2.2.2.2.2.3、Surgical History

Surgical History

Other Surgery

2.2.2.2.2.4、Family Cancer History

Family Cancer History

No

2.2.2.2.2.5、Comorbidity

Comorbidity

Hypertension

2.2.2.2.2.6、Pulmonary Nodules on Past Chest CT

Pulmonary Nodules on Past Chest CT

Not Done

2.3.Exhaled Breath Collection Person

Exhaled Breath Collection Person

ZXZ

2.4.Exhaled Breath Collection Date

Exhaled Breath Collection Date

2020-01-02 yyyy-mm-dd

2.5.Data Entry Clerk

Data Entry Clerk

ZXZ

2.6.Data Entry Date

Data Entry Date

2020-01-02 yyyy-mm-dd

2.7.Quality Control Person

Quality Control Person

2.8.Quality Control Date

Quality Control Date

yyyy-mm-dd

3.Auxiliary Examination For Lung Cancer Subject Only
3.1.Tumor Marker

Tumor Marker Increase

3.2.FVC

FVC

1.74 L

3.3.FVC%

FVC%

91.7 %

3.4.FEV1

FEV1

1.54 L

3.5.FEV1%

FEV1%

99.2 %

3.6.FEV1/FVC

FEV1/FVC

88.63 %

3.7.MVV%

MVV%

98.1 %

3.8.DLCO SB%

DLCO SB%

130.3 %

3.9.Tumor Shape on Chest CT

Tumor Shape on Chest CT

Part-Solid Nodule

3.10.Tumor Maximum Diameter on Chest CT

Tumor Maximum Diameter on Chest CT

2.4 cm

3.11.Lymph Node on Chest CT

Lymph Node on Chest CT

cN1-2(-)

3.12.PET-CT

PET-CT SUVmax

Not Done

4.Treatment For Lung Cancer Subject Only
4.1.Surgery
4.4.1.4.1.1、Tumor Location

Tumor Location

Left Upper Lobe

4.4.1.4.1.2、Surgical Approach

Surgical Approach

Four Port VATS

4.4.1.4.1.3、Type of Resection

Type of Resection

Wedge Resection

4.4.1.4.1.4、Operative Time

Operative Time

150 minutes

4.4.1.4.1.5、Intraoperative Blood Loss

Intraoperative Blood Loss

50 ml

4.4.1.4.1.6、Intraoperative Blood Transfusion

Intraoperative Blood Transfusion

No

4.4.1.4.1.7、Surgeon Name

Surgeon Name

Qiang Li

4.4.1.4.1.8、Surgical Margin

Surgical Margin

No Residual Tumor

4.4.1.4.1.9、Pathological Type

Pathological Type

Adenocarcinoma

4.4.1.4.1.10、Lymphovascular Invasion

Lymphovascular Invasion

No

4.4.1.4.1.11、Perineural Invasion

Perineural Invasion

No

4.4.1.4.1.12、Gene Mutation

Gene Mutation

Not Done

4.4.1.4.1.13、pT Stage

pT Stage, Eighth Edition

T1c

4.4.1.4.1.14、pN Stage

pN Stage, Eighth Edition

N0

4.4.1.4.1.15、Stations of N1 Lymph Nodes

Stations of N1 Lymph Nodes

Two Stations

4.4.1.4.1.16、Numbers of N1 Lymph Nodes

Numbers of N1 Lymph Nodes

6

4.4.1.4.1.17、Numbers of Metastatic N1 Lymph Nodes

Numbers of Metastatic N1 Lymph Nodes

0

4.4.1.4.1.18、Stations of N2 Lymph Nodes

Stations of N2 Lymph Nodes

Four Stations

4.4.1.4.1.19、Numbers of N2 Lymph Nodes

Numbers of N2 Lymph Nodes

5

4.4.1.4.1.20、Numbers of Metastatic N2 Lymph Nodes

Numbers of Metastatic N2 Lymph Nodes

0

4.4.1.4.1.21、Dissection of Station 7

Dissection of Station 7

Yes

4.4.1.4.1.22、Highest N2 Status

Highest N2 Status

Negative

4.4.1.4.1.23、Types of Lymph Node Dissection

Types of Lymph Node Dissection

Selective Lymph Node Sampling

4.4.1.4.1.24、pM Stage

pM Stage, Eighth Edition

M0

4.4.1.4.1.25、pTNM Stage

pTNM Stage, Eighth Edition

Stage IA3

4.4.1.4.1.26、Postoperative Complications

Postoperative Complications

No

4.2.Non-Surgical Treatment

Non-Surgical Treatment

4.3.Time point
4.4.3.4.31、Admission Date

Admission Date

2019-12-26 yyyy-mm-dd

4.4.3.4.32、Discharge Date

Discharge Date

2020-01-07 yyyy-mm-dd

4.4.3.4.33、Surgery Date

Surgery Date

2020-01-02 yyyy-mm-dd

5.Exhaled Breath Analysis Data Saved In SCU
5.1.Volatile Organic Compounds

Volatile Organic Compounds